Stock Events

Stock Events

Hikma Pharmaceuticals (HIK.LSE) Q3 2024 Earnings

8AugConfirmed

Q4 2022

Q2 2023

Q1 2024

Q3 2024

0.91

33.82

66.73

99.63

Details

Expected EPS

N/A

Actual EPS

99.63404

Surprise EPS

99.63

Surprise Percent

+∞%

Description

Hikma Pharmaceuticals (HIK.LSE) has reported earnings of 99.63404 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.